SethJ.BaumMD
Cardiology • Boca Raton, FLAdult Congenital Heart Disease, Cardiac Electrophysiology, Preventive Cardiology
Preventive Cardiology, Inc. Lipidologist Author, Lecturer Consultant
Dr. Baum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7900 Glades Rd
Suite 400
Boca Raton, FL 33434Phone+1 561-488-5535Fax+1 561-488-2150
Education & Training
New York Medical College at St Vincent's Hospital and Medical Center of New YorkFellowship, Cardiovascular Disease, 1988 - 1990
NYU Grossman School of MedicineInternship, Internal Medicine, 1985 - 1986
Columbia University Vagelos College of Physicians and SurgeonsClass of 1985
Certifications & Licensure
FL State Medical License 1991 - 2026
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Effect of Relora Supplement on Anxiety, Cognitive Performance & Mood Tested After Induced Stress Start of enrollment: 2016 Feb 01
- Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients Start of enrollment: 2019 Dec 04
- Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia Start of enrollment: 2021 Feb 16
Roles: Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Olpasiran lowering of lipoprotein(a) according to baseline levels: insights from the OCEAN(a)-DOSE study.Gurleen Kaur, Robert S Rosenson, Baris Gencer, J Antonio G López, Norman E Lepor
European Heart Journal. 2025-03-24 - 1 citationsEffects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity.Michael R Zile, Barry A Borlaug, Christopher M Kramer, Seth J Baum, Sheldon E Litwin
Circulation. 2025-03-11 - Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers: Results From the OCEAN(a)-DOSE Trial.Robert S Rosenson, J Antonio G López, Daniel Gaudet, Seth J Baum, Elmer Stout
JAMA Cardiology. 2025-02-12
Journal Articles
- The Present and Future JACC Scientific Expert Panel Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert PanelJoshua W Knowles, Seth J Baum, MacRae F Linton, Nathan O Stitziel, Daniel J Rader, Samuel S Gidding, Ray E Hershberger, Zahid S Ahmad, Christie M Ballantyne, ScienceDirect
Press Mentions
Medscape and ACC Centers of ExcellenceNovember 2nd, 2021- Madrigal Pharmaceuticals to Present Secondary Analyses of Data from Phase 2 NASH Study of Resmetirom and Symposium at the Digital International Liver Congress™ 2020August 26th, 2020
Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV EventsJuly 25th, 2019- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
